Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inflammatory Breast Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02556632
What this trial is testing

Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer

Who this might be right for
Breast CarcinomaPainRadiation-Induced Dermatitis+1 more
Gary Morrow 191
Early research (Phase 1)UnknownNCT04660929
What this trial is testing

CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors

Who this might be right for
HER2-positiveAdenocarcinomaBile Duct Cancer+28 more
Carisma Therapeutics Inc 48
Not applicableStudy completedNCT01411943
What this trial is testing

Epigenetics and Psychoneurologic Symptoms in Women With Breast Cancer

Who this might be right for
Breast Cancer
Virginia Commonwealth University 75
Testing effectiveness (Phase 2)Study completedNCT00111787
What this trial is testing

Study Of Lapatinib In Combination With Paclitaxel In The Treatment Of Newly Diagnosed Inflammatory Breast Cancer

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline 49
Not applicableLooking for participantsNCT06966050
What this trial is testing

Multi-center MRD Registry for Inflammatory Breast Cancer

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 200
Large-scale testing (Phase 3)Ended earlyNCT00016276
What this trial is testing

Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer

Who this might be right for
Cardiac ToxicityInflammatory Breast CancerStage IIIA Breast Cancer+2 more
National Cancer Institute (NCI) 396
Early research (Phase 1)Study completedNCT03109080
What this trial is testing

Olaparib & Radiation Therapy for Patients Triple Negative Breast Cancer (TNBC)

Who this might be right for
Breast Neoplasms, Triple-NegativeBreast Neoplasm Malignant FemaleRadiotherapy Side Effect
Institut Curie 24
Large-scale testing (Phase 3)WithdrawnNCT00397761
What this trial is testing

Capecitabine and Paclitaxel (Albumin-Stabilized Nanoparticle Formulation) in Treating Women Undergoing Surgery for Stage II or Stage III Breast Cancer

Who this might be right for
Breast Cancer
Medstar Health Research Institute
Not applicableActive Not RecruitingNCT02647385
What this trial is testing

Pain Control in Breast Surgery: Analgesia, Opioid Consumption and Inflammatory Response Evaluation

Who this might be right for
Breast CancerAnesthesia
Hospital Sirio-Libanes 50
Not applicableStudy completedNCT06954324
What this trial is testing

Investigation of the Effect of Erector Spinae Plane Block on Systemic Immuno-Inflammatory Index

Who this might be right for
Erector Spinae Plane BlockSystemic Immune-inflammatory IndexBreast Cancer
Namik Kemal University 120
Not applicableLooking for participantsNCT04913064
What this trial is testing

Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancer

Who this might be right for
Breast Carcinoma
City of Hope Medical Center 26
Testing effectiveness (Phase 2)Study completedNCT00513695
What this trial is testing

Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer

Who this might be right for
Inflammatory Breast CancerMale Breast CancerStage II Breast Cancer+3 more
University of Washington 68
Testing effectiveness (Phase 2)Active Not RecruitingNCT01525966
What this trial is testing

Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast Cancer

Who this might be right for
Inflammatory Breast CancerStage IIA Breast CancerStage IIIA Breast Cancer+7 more
City of Hope Medical Center 67
Large-scale testing (Phase 3)Study completedNCT00288002
What this trial is testing

Combination Chemotherapy With or Without Capecitabine and/or Trastuzumab Before Surgery in Treating Women With Stage I, Stage II, or Stage III Breast Cancer

Who this might be right for
Breast Cancer
GBG Forschungs GmbH 1,500
Not applicableEnrolling By InvitationNCT06447532
What this trial is testing

Use of Machine Learning Techniques for Serial Assessment of Systemic Inflammatory Markers in Breast Cancer Patients

Who this might be right for
Breast Cancer
Federal University of São Paulo 4,500
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT00072319
What this trial is testing

Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Study completedNCT02324088
What this trial is testing

Interest of Maintenance Chemotherapy After Induction Treatment for Inflammatory Breast Cancer

Who this might be right for
Inflammatory Breast Cancer
UNICANCER 174
Testing effectiveness (Phase 2)Study completedNCT01262027
What this trial is testing

TKI258 for Metastatic Inflammatory Breast Cancer Patients

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 22
Testing effectiveness (Phase 2)Ended earlyNCT00756470
What this trial is testing

Phase II Neoadjuvant in Inflammatory Breast Cancer

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 15
Next Page